Aspen Pharmacare Operating Income 2017-2023 | APNHY
Aspen Pharmacare annual/quarterly operating income history and growth rate from 2017 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Aspen Pharmacare operating income for the quarter ending June 30, 2023 was $M, a NAN% increase year-over-year.
- Aspen Pharmacare operating income for the twelve months ending June 30, 2023 was $0M, a NAN% increase year-over-year.
- Aspen Pharmacare annual operating income for 2023 was $0.441B, a 22.68% decline from 2022.
- Aspen Pharmacare annual operating income for 2022 was $0.571B, a 23.74% increase from 2021.
- Aspen Pharmacare annual operating income for 2021 was $0.461B, a 1.41% increase from 2020.
Aspen Pharmacare Annual Operating Income
(Millions of US $) |
| 2023 |
$441 |
| 2022 |
$571 |
| 2021 |
$461 |
| 2020 |
$455 |
| 2019 |
$339 |
| 2018 |
$721 |
| 2017 |
$610 |
| 2016 |
$625 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Operating Income
(Millions of US $) |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.328B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
